Drug intelligence / Profile preview

Sunphenon EGCG

Development stage
Phase 3
Lead developer
Taiyo Kagaku
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Sunphenon EGCG is a high-purity, decaffeinated green tea extract standardized to contain more than 94% epigallocatechin gallate (EGCg), the major catechin found in green tea leaves (Camellia sinensis)[3][4][9]. It is produced via water infusion and decaffeination using food-grade solvents to ensure compliance with stringent safety standards[1][9]. Sunphenon EGCG is marketed as a 100% natural ingredient for use in dietary supplements, functional foods and beverages, and cosmetics[3][4]. The primary mechanism of action of EGCg involves its antioxidant activity—scavenging free radicals and reducing oxidative stress. Additional reported effects include anti-inflammatory activity, thermogenic effects that may aid weight management, antimicrobial properties, and potential cardiovascular benefits[8][9]. Clinical studies have explored its use in conditions such as relapsing-remitting multiple sclerosis[5].

Brand names
Sunphenon EGCG
Other names
Epigallocatechin gallateEGCgGreen tea extract (high-purity EGCg)Sunphenon EGCg
02

Targets

CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP3A4 (Cytochrome P450 3A4)

Beyond the preview

Go deeper on Sunphenon EGCG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunphenon EGCG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call